{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762752",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762752_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"acebutolol\" outputclass=\"int-drug\">acebutolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  acebutolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762752_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"acebutolol\" outputclass=\"int-drug\">acebutolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   acebutolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Acebutolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762753",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762753_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"alectinib\" outputclass=\"int-drug\">alectinib</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  alectinib  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alectinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762754",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762754_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"alfentanil\" outputclass=\"int-drug\">alfentanil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  alfentanil  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Alfentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762755",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762755_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"amiodarone\" outputclass=\"int-drug\">amiodarone</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  amiodarone  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762755_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"amiodarone\" outputclass=\"int-drug\">Amiodarone</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Amiodarone   increases   the risk of bradycardia when given with   rivastigmine .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Amiodarone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762756",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762756_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"apraclonidine\" outputclass=\"int-drug\">apraclonidine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  apraclonidine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Apraclonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762757",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762757_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"atenolol\" outputclass=\"int-drug\">atenolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  atenolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762757_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"atenolol\" outputclass=\"int-drug\">atenolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   atenolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762758",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762758_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"atracurium\" outputclass=\"int-drug\">atracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Rivastigmine   is predicted to   decrease   the effects of   atracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Atracurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762759",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762759_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"betaxolol\" outputclass=\"int-drug\">betaxolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  betaxolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762759_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"betaxolol\" outputclass=\"int-drug\">betaxolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   betaxolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Betaxolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762760",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762760_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"bisoprolol\" outputclass=\"int-drug\">bisoprolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  bisoprolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762760_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"bisoprolol\" outputclass=\"int-drug\">bisoprolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   bisoprolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Bisoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762761",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762761_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"brimonidine\" outputclass=\"int-drug\">brimonidine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  brimonidine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Brimonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762762",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762762_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"carvedilol\" outputclass=\"int-drug\">carvedilol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  carvedilol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762762_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"carvedilol\" outputclass=\"int-drug\">carvedilol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   carvedilol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Carvedilol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762763",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762763_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"celiprolol\" outputclass=\"int-drug\">celiprolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  celiprolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762763_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"celiprolol\" outputclass=\"int-drug\">celiprolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   celiprolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Celiprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762764",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762764_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"cisatracurium\" outputclass=\"int-drug\">cisatracurium</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  cisatracurium  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762764_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"cisatracurium\" outputclass=\"int-drug\">cisatracurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   decrease   the effects of   cisatracurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Cisatracurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762765",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762765_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"clonidine\" outputclass=\"int-drug\">clonidine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  clonidine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Clonidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762766",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762766_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"crizotinib\" outputclass=\"int-drug\">crizotinib</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  crizotinib  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "15",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Crizotinib</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762767",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762767_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"digoxin\" outputclass=\"int-drug\">digoxin</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  digoxin  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "16",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Digoxin</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762768",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762768_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"diltiazem\" outputclass=\"int-drug\">diltiazem</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  diltiazem  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762768_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"diltiazem\" outputclass=\"int-drug\">Diltiazem</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Diltiazem   increases   the risk of bradycardia when given with   rivastigmine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "17",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Diltiazem</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762769",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762769_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"esmolol\" outputclass=\"int-drug\">esmolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  esmolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762769_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"esmolol\" outputclass=\"int-drug\">esmolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   esmolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "18",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Esmolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762770",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762770_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"fentanyl\" outputclass=\"int-drug\">fentanyl</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  fentanyl  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "19",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fentanyl</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762771",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762771_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"fingolimod\" outputclass=\"int-drug\">fingolimod</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  fingolimod  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "20",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Fingolimod</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762772",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762772_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"flecainide\" outputclass=\"int-drug\">flecainide</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  flecainide  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "21",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Flecainide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762773",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762773_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"ivabradine\" outputclass=\"int-drug\">ivabradine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  ivabradine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "22",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Ivabradine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762774",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762774_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"labetalol\" outputclass=\"int-drug\">labetalol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  labetalol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762774_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"labetalol\" outputclass=\"int-drug\">labetalol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   labetalol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "23",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Labetalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762775",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762775_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"levobunolol\" outputclass=\"int-drug\">levobunolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  levobunolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762775_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"levobunolol\" outputclass=\"int-drug\">levobunolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   levobunolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "24",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Levobunolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762776",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762776_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"methadone\" outputclass=\"int-drug\">methadone</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  methadone  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "25",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Methadone</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762777",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762777_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"metoprolol\" outputclass=\"int-drug\">metoprolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  metoprolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762777_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"metoprolol\" outputclass=\"int-drug\">metoprolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   metoprolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "26",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Metoprolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762778",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762778_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"mivacurium\" outputclass=\"int-drug\">mivacurium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Rivastigmine   is predicted to   decrease   the effects of   mivacurium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "27",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Mivacurium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762779",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762779_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"nadolol\" outputclass=\"int-drug\">nadolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  nadolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762779_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"nadolol\" outputclass=\"int-drug\">nadolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   nadolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "28",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nadolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762780",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762780_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"nebivolol\" outputclass=\"int-drug\">nebivolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  nebivolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762780_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"nebivolol\" outputclass=\"int-drug\">nebivolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   nebivolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "29",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Nebivolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762781",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762781_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"neostigmine\" outputclass=\"int-drug\">neostigmine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  neostigmine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "30",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Neostigmine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762782",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762782_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"oxprenolol\" outputclass=\"int-drug\">oxprenolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  oxprenolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762782_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"oxprenolol\" outputclass=\"int-drug\">oxprenolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   oxprenolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "31",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Oxprenolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762783",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762783_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"pancuronium\" outputclass=\"int-drug\">pancuronium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Rivastigmine   is predicted to   decrease   the effects of   pancuronium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "32",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pancuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762784",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762784_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"pasireotide\" outputclass=\"int-drug\">pasireotide</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  pasireotide  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "33",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pasireotide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762785",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762785_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"pindolol\" outputclass=\"int-drug\">pindolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  pindolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762785_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"pindolol\" outputclass=\"int-drug\">pindolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   pindolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "34",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pindolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762786",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762786_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"propranolol\" outputclass=\"int-drug\">propranolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  propranolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762786_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"propranolol\" outputclass=\"int-drug\">propranolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   propranolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "35",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Propranolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762787",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762787_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"pyridostigmine\" outputclass=\"int-drug\">pyridostigmine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  pyridostigmine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "36",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Pyridostigmine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762788",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762788_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"remifentanil\" outputclass=\"int-drug\">remifentanil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  remifentanil  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "37",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Remifentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762789",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762789_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"rocuronium\" outputclass=\"int-drug\">rocuronium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Rivastigmine   is predicted to   decrease   the effects of   rocuronium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "38",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Rocuronium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762790",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762790_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"selegiline\" outputclass=\"int-drug\">selegiline</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  selegiline  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "39",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Selegiline</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762791",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762791_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"sotalol\" outputclass=\"int-drug\">sotalol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  sotalol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762791_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"sotalol\" outputclass=\"int-drug\">sotalol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   sotalol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "40",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sotalol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762792",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762792_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"sufentanil\" outputclass=\"int-drug\">sufentanil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  sufentanil  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "41",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sufentanil</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762793",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762793_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the effects of</ph> <ph otherprops=\"suxamethonium\" outputclass=\"int-drug\">suxamethonium</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Moderate",
							"hasOrder": "1",
							"hasTextContent": "Rivastigmine   increases   the effects of   suxamethonium .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "42",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Suxamethonium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762794",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762794_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"thalidomide\" outputclass=\"int-drug\">thalidomide</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  thalidomide  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "43",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Thalidomide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762795",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762795_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"timolol\" outputclass=\"int-drug\">timolol</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  timolol  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762795_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">Rivastigmine</ph> <ph outputclass=\"int-effectQualifier\">is predicted to</ph> <ph outputclass=\"int-effect\">increase</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"timolol\" outputclass=\"int-drug\">timolol</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Rivastigmine   is predicted to   increase   the risk of bradycardia when given with   timolol .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "44",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Timolol</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762796",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762796_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"tizanidine\" outputclass=\"int-drug\">tizanidine</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  tizanidine  can increase the risk of bradycardia. \n\n"
						}
					],
					"hasOrder": "45",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Tizanidine</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762797",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762797_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Normal\" outputclass=\"int-message\">Both <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph> and <ph otherprops=\"verapamil\" outputclass=\"int-drug\">verapamil</ph> can increase the risk of bradycardia.</p>"
							},
							"hasEvidence": "NotSet",
							"hasImportance": "NotSet",
							"hasOrder": "1",
							"hasTextContent": "Both  rivastigmine  and  verapamil  can increase the risk of bradycardia. \n\n"
						},
						{
							"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2#bnf_i1557280762797_message_1",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Moderate\" outputclass=\"int-message\">\n  <ph otherprops=\"verapamil\" outputclass=\"int-drug\">Verapamil</ph> <ph outputclass=\"int-effect\">increases</ph> <ph outputclass=\"int-parameter\">the risk of bradycardia when given with</ph> <ph otherprops=\"rivastigmine\" outputclass=\"int-heading-drug\">rivastigmine</ph>. <ph outputclass=\"int-action\">Manufacturer advises caution</ph>.  </p>"
							},
							"hasEvidence": "Anecdotal",
							"hasImportance": "Moderate",
							"hasOrder": "2",
							"hasTextContent": "Verapamil   increases   the risk of bradycardia when given with   rivastigmine .  Manufacturer advises caution .    \n\n"
						}
					],
					"hasOrder": "46",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Verapamil</title>"
					}
				}
			],
			"hasSearchLabel": " Rivastigmine  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/rivastigmine-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Rivastigmine </title>"
			},
			"rdfs:label": "rivastigmine"
		}
	]
}